⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NAGE News
Niagen Bioscience, Inc. Common Stock
Niagen Bioscience to Present at Canaccord Genuity’s 46th Annual Growth Conference
businesswire.com
NAGE
Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research
businesswire.com
NAGE
Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia Telangiectasia (A-T)
businesswire.com
NAGE
Niagen Bioscience CEO Rob Fried to Participate in Virtual Fireside Chat to Discuss Pharmaceutical Strategy on July 15, 2026
businesswire.com
NAGE
Niagen Bioscience Launches Pharmaceutical Program for Accelerated Aging and Rare Genetic Diseases
businesswire.com
NAGE
Form 8-K
sec.gov
NAGE
Niagen Bioscience to Present at the 16th Annual East Coast IDEAS Investor Conference
businesswire.com
NAGE
Niagen Bioscience Renames ChromaDex External Research Program to the Niagen Research Program, Strengthening Position as the Global Leader in NAD+ Science
businesswire.com
NAGE
Niagen Bioscience Announces Participation in Upcoming Investor Conferences
businesswire.com
NAGE
The Benchmark Company Announces 4th Annual Consumer One-on-One Conference in New York City
globenewswire.com
SNEX
BJRI
CALM
DIN
FWRG
FRPT
JJSF
KRUS
LIND
MBUU
NAGE
ONEW
PATK
PAG
SAH
ANDE
CHEF
STKS
WEST